Interest of Molecular Analysis of Cerebral Thrombi in Determining the Prognosis and Etiology of Cerebral Infarction

NCT ID: NCT05658835

Last Updated: 2024-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

311 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-08

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The MATISSE (Molecular Analysis of Thrombus for Ischemic Stroke prognosis and Etiology) project evaluates the hypothesis that the molecular composition of cerebral thrombus in metabolites, lipids, and proteins conditions the clinical prognosis at 3 months of the infarction and informs on its etiological subtype

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient suffering from ischemic stroke

Thrombi and blood analyses

Intervention Type OTHER

Thrombi and blood will be collected during thrombectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thrombi and blood analyses

Thrombi and blood will be collected during thrombectomy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female 18 years of age or older;
* Patient with a cerebral infarction documented by brain imaging who received endovascular treatment by mechanical thrombectomy;
* Patient for whom it was possible to collect cerebral thrombus for LC-MS analysis during mechanical thrombectomy:
* Patient who was informed of the study and formulated a non-opposition to participation. If not, patient for whom a relative was informed and formulated a non-opposition.

Exclusion Criteria

* Patient with a cerebral infarction documented by cerebral imaging, having benefited from an endovascular treatment with mechanical thrombectomy that did not allow the extraction of a cerebral thrombus.
* Protected persons (articles L1121-5, L1121-6 and L121-8 of the Public Health Code): pregnant or breast-feeding women, persons deprived of liberty, under guardianship or curatorship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François Crémieux

Role: STUDY_DIRECTOR

AP-HM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Martinique

Fort-de-France, , France

Site Status RECRUITING

Stroke Center

Marseille, , France

Site Status RECRUITING

CHU Guadeloupe

Pointe à Pitre, , France

Site Status RECRUITING

CHU La Réunion

Saint-Pierre, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emilie Doche

Role: CONTACT

04 91 38 78 65 ext. 33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Quentin Bourgeois

Role: primary

Emilie DOCHE

Role: primary

Anne Landais

Role: primary

Mirebeau Gabriel

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ID-RCB

Identifier Type: OTHER

Identifier Source: secondary_id

RCAPHM22_0231

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diffusion Spectroscopy in Stroke
NCT02833961 COMPLETED NA
A Novel Method for Determination of Thromboembolic Stroke Origin
NCT06961604 NOT_YET_RECRUITING EARLY_PHASE1